Sonus Finds Way Out through Merger with OncoGenex

By Sally Mardikian PhD

Pharma Deals Review: Vol 2008 Issue 96 (Table of Contents)

Published: 29 May-2008

DOI: 10.3833/pdr.v2008.i96.179     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Sonus Pharmaceuticals has overcome disappointing Phase III failure in late 2007 by merging with OncoGenex to form OncoGenex Pharmaceuticals, a company with an array of promising oncology clinical candidates...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details